Free Trial

Translational Development Acquisition (TDACU) Competitors

Translational Development Acquisition logo
$11.97 -0.73 (-5.74%)
As of 11:03 AM Eastern
This is a fair market value price provided by Massive. Learn more.

TDACU vs. ONCHU, ONCHW, ASPCU, AACOU, and ACGCU

Should you buy Translational Development Acquisition stock or one of its competitors? MarketBeat compares Translational Development Acquisition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Translational Development Acquisition include 1RT Acquisition (ONCHU), 1RT Acquisition (ONCHW), A SPAC III Acquisition (ASPCU), Abony Acquisition Corp I (AACOU), and ACP Holdings Acquisition (ACGCU). These companies are all part of the "trading" industry.

How does Translational Development Acquisition compare to 1RT Acquisition?

1RT Acquisition (NASDAQ:ONCHU) and Translational Development Acquisition (NASDAQ:TDACU) are both investment offices industry companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

In the previous week, Translational Development Acquisition had 1 more articles in the media than 1RT Acquisition. MarketBeat recorded 4 mentions for Translational Development Acquisition and 3 mentions for 1RT Acquisition. 1RT Acquisition's average media sentiment score of 0.96 beat Translational Development Acquisition's score of 0.22 indicating that 1RT Acquisition is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
1RT Acquisition
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Translational Development Acquisition
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1RT AcquisitionN/AN/AN/AN/AN/A
Translational Development AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
1RT AcquisitionN/A N/A N/A
Translational Development Acquisition N/A N/A N/A

Summary

1RT Acquisition and Translational Development Acquisition tied by winning 1 of the 2 factors compared between the two stocks.

How does Translational Development Acquisition compare to 1RT Acquisition?

Translational Development Acquisition (NASDAQ:TDACU) and 1RT Acquisition (NASDAQ:ONCHW) are both investment offices industry companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

Company Net Margins Return on Equity Return on Assets
Translational Development AcquisitionN/A N/A N/A
1RT Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Translational Development AcquisitionN/AN/AN/AN/AN/A
1RT AcquisitionN/AN/AN/AN/AN/A

In the previous week, Translational Development Acquisition had 3 more articles in the media than 1RT Acquisition. MarketBeat recorded 4 mentions for Translational Development Acquisition and 1 mentions for 1RT Acquisition. 1RT Acquisition's average media sentiment score of 1.87 beat Translational Development Acquisition's score of 0.22 indicating that 1RT Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Translational Development Acquisition Neutral
1RT Acquisition Very Positive

Summary

Translational Development Acquisition and 1RT Acquisition tied by winning 1 of the 2 factors compared between the two stocks.

How does Translational Development Acquisition compare to A SPAC III Acquisition?

Translational Development Acquisition (NASDAQ:TDACU) and A SPAC III Acquisition (NASDAQ:ASPCU) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

Company Net Margins Return on Equity Return on Assets
Translational Development AcquisitionN/A N/A N/A
A SPAC III Acquisition N/A N/A N/A

In the previous week, Translational Development Acquisition had 3 more articles in the media than A SPAC III Acquisition. MarketBeat recorded 4 mentions for Translational Development Acquisition and 1 mentions for A SPAC III Acquisition. A SPAC III Acquisition's average media sentiment score of 1.87 beat Translational Development Acquisition's score of 0.22 indicating that A SPAC III Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Translational Development Acquisition Neutral
A SPAC III Acquisition Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Translational Development AcquisitionN/AN/AN/AN/AN/A
A SPAC III AcquisitionN/AN/AN/AN/AN/A

Summary

Translational Development Acquisition and A SPAC III Acquisition tied by winning 1 of the 2 factors compared between the two stocks.

How does Translational Development Acquisition compare to Abony Acquisition Corp I?

Translational Development Acquisition (NASDAQ:TDACU) and Abony Acquisition Corp I (NASDAQ:AACOU) are both investment offices industry companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Translational Development AcquisitionN/A N/A N/A
Abony Acquisition Corp I N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Translational Development AcquisitionN/AN/AN/AN/AN/A
Abony Acquisition Corp IN/AN/AN/AN/AN/A

In the previous week, Translational Development Acquisition had 2 more articles in the media than Abony Acquisition Corp I. MarketBeat recorded 4 mentions for Translational Development Acquisition and 2 mentions for Abony Acquisition Corp I. Abony Acquisition Corp I's average media sentiment score of 1.44 beat Translational Development Acquisition's score of 0.22 indicating that Abony Acquisition Corp I is being referred to more favorably in the news media.

Company Overall Sentiment
Translational Development Acquisition Neutral
Abony Acquisition Corp I Positive

Summary

Translational Development Acquisition and Abony Acquisition Corp I tied by winning 1 of the 2 factors compared between the two stocks.

How does Translational Development Acquisition compare to ACP Holdings Acquisition?

ACP Holdings Acquisition (NASDAQ:ACGCU) and Translational Development Acquisition (NASDAQ:TDACU) are both investment offices industry companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
ACP Holdings AcquisitionN/A N/A N/A
Translational Development Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ACP Holdings AcquisitionN/AN/AN/AN/AN/A
Translational Development AcquisitionN/AN/AN/AN/AN/A

In the previous week, Translational Development Acquisition had 2 more articles in the media than ACP Holdings Acquisition. MarketBeat recorded 4 mentions for Translational Development Acquisition and 2 mentions for ACP Holdings Acquisition. ACP Holdings Acquisition's average media sentiment score of 1.44 beat Translational Development Acquisition's score of 0.22 indicating that ACP Holdings Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
ACP Holdings Acquisition Positive
Translational Development Acquisition Neutral

Summary

ACP Holdings Acquisition and Translational Development Acquisition tied by winning 1 of the 2 factors compared between the two stocks.

Get Translational Development Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for TDACU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TDACU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TDACU vs. The Competition

MetricTranslational Development AcquisitionInvestment Offices IndustryFinance SectorNASDAQ Exchange
Market CapN/A$320.60M$13.53B$11.72B
Dividend YieldN/AN/A5.79%5.61%
P/E RatioN/A2.2719.9723.78
Price / SalesN/A39,849.90134.1485.99
Price / CashN/A136.1219.3154.72
Price / BookN/A348.522.206.71
Net IncomeN/A-$66.73M$1.14B$337.26M
7 Day Performance6.36%0.08%0.19%-2.08%
1 Month Performance14.66%2.86%0.36%0.74%
1 Year Performance16.34%4.75%10.27%24.42%

Translational Development Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TDACU
Translational Development Acquisition
N/A$11.97
-5.7%
N/A+15.2%$0.00N/AN/AN/A
ONCHU
1RT Acquisition
N/A$10.37
+0.2%
N/AN/A$0.00N/AN/A2
ONCHW
1RT Acquisition
N/A$0.45
-8.2%
N/AN/A$0.00N/AN/A2
ASPCU
A SPAC III Acquisition
N/A$11.05
-7.9%
N/A+13.5%$0.00N/AN/AN/A
AACOU
Abony Acquisition Corp I
N/A$10.31
+2.9%
N/AN/A$0.00N/AN/A2

Related Companies and Tools


This page (NASDAQ:TDACU) was last updated on 6/11/2026 by MarketBeat.com Staff.
From Our Partners